French firm has entered a multiyear exclusive collaboration and licence agreement with Germany-based BioNTech to discover and develop up to five cancer immunotherapies.
Source: Sanofi and BioNTech partner to develop five new cancer immunotherapies – Pharmaceutical Technology
